Aroa Biosurgery Statistics
Total Valuation
Aroa Biosurgery has a market cap or net worth of 171.54 million. The enterprise value is 161.20 million.
| Market Cap | 171.54M |
| Enterprise Value | 161.20M |
Important Dates
The last earnings date was Tuesday, January 27, 2026.
| Earnings Date | Jan 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 345.48M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.19% |
| Shares Change (QoQ) | -0.08% |
| Owned by Insiders (%) | 25.15% |
| Owned by Institutions (%) | 32.36% |
| Float | 258.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 51.24 |
| PS Ratio | 3.27 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.77 |
| P/FCF Ratio | 58.68 |
| P/OCF Ratio | 47.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 51.52, with an EV/FCF ratio of 55.14.
| EV / Earnings | -152.74 |
| EV / Sales | 2.87 |
| EV / EBITDA | 51.52 |
| EV / EBIT | n/a |
| EV / FCF | 55.14 |
Financial Position
The company has a current ratio of 6.52, with a Debt / Equity ratio of 0.08.
| Current Ratio | 6.52 |
| Quick Ratio | 5.60 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 1.39 |
| Debt / FCF | 1.39 |
| Interest Coverage | 1.45 |
Financial Efficiency
Return on equity (ROE) is -1.97% and return on invested capital (ROIC) is 0.40%.
| Return on Equity (ROE) | -1.97% |
| Return on Assets (ROA) | 0.37% |
| Return on Invested Capital (ROIC) | 0.40% |
| Return on Capital Employed (ROCE) | 0.64% |
| Weighted Average Cost of Capital (WACC) | 8.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.56 |
Taxes
In the past 12 months, Aroa Biosurgery has paid 255,146 in taxes.
| Income Tax | 255,146 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.78 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 28,064 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aroa Biosurgery had revenue of 52.42 million and -1.06 million in losses. Loss per share was -0.00.
| Revenue | 52.42M |
| Gross Profit | 44.59M |
| Operating Income | 365,323 |
| Pretax Income | -800,232 |
| Net Income | -1.06M |
| EBITDA | 2.22M |
| EBIT | 365,323 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 13.71 million in cash and 4.07 million in debt, with a net cash position of 9.64 million.
| Cash & Cash Equivalents | 13.71M |
| Total Debt | 4.07M |
| Net Cash | 9.64M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 53.56M |
| Book Value Per Share | 0.16 |
| Working Capital | 33.40M |
Cash Flow
In the last 12 months, operating cash flow was 3.64 million and capital expenditures -719,629, giving a free cash flow of 2.92 million.
| Operating Cash Flow | 3.64M |
| Capital Expenditures | -719,629 |
| Free Cash Flow | 2.92M |
| FCF Per Share | n/a |
Margins
Gross margin is 85.07%, with operating and profit margins of 0.70% and -2.01%.
| Gross Margin | 85.07% |
| Operating Margin | 0.70% |
| Pretax Margin | -1.53% |
| Profit Margin | -2.01% |
| EBITDA Margin | 4.23% |
| EBIT Margin | 0.70% |
| FCF Margin | 5.58% |
Dividends & Yields
Aroa Biosurgery does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.19% |
| Shareholder Yield | -0.19% |
| Earnings Yield | -0.62% |
| FCF Yield | 1.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aroa Biosurgery has an Altman Z-Score of 8.68 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.68 |
| Piotroski F-Score | 4 |